MARKET

ATAI

ATAI

Atai Life Sciences B.V.
NASDAQ
1.790
-0.030
-1.65%
After Hours: 1.780 -0.01 -0.56% 19:47 01/27 EST
OPEN
1.810
PREV CLOSE
1.820
HIGH
1.840
LOW
1.770
VOLUME
1.21M
TURNOVER
0
52 WEEK HIGH
6.32
52 WEEK LOW
1.450
MARKET CAP
296.92M
P/E (TTM)
-1.3913
1D
5D
1M
3M
1Y
5Y
Top 3 Psychedelic Storylines To Watch In 2023
Benzinga · 6h ago
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga · 2d ago
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
Benzinga · 3d ago
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Benzinga · 4d ago
Numinus Wellness: Cash Burn Concern (Rating Downgrade)
Seeking Alpha · 4d ago
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
Benzinga · 5d ago
Psychedelic Stock Gainers And Losers From January 23, 2023
Benzinga · 6d ago
This Analyst Still Has Confidence In Atai Life Sciences' Pipeline Despite Recent Setbacks
Benzinga · 01/19 18:24
More
About ATAI
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.

Webull offers kinds of ATAI Life Sciences NV stock information, including NASDAQ:ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.